Earnings Feed
Start Free
Home/Filings/4/0001104659-17-072516
4//SEC Filing

Cashman Christopher Michael 4

Accession 0001104659-17-072516

CIK 0001267813other
View on SEC.govCompany Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:05 PM ET

Size

5.2 KB

Accession

0001104659-17-072516

Insider Transaction Report

Form 4
Period: 2017-12-06
MARINUS PHARMACEUTICALS INCMRNS
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
  • Award

    Stock option (right to buy)

    2017-12-06+500,000→ 500,000 total
    Exercise: $6.19Exp: 2027-12-06→ Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]Options to purchase shares of common stock vest in 36 equal monthly installments commencing 1/1/2018.

Documents

1 file

Issuer

MARINUS PHARMACEUTICALS INC

CIK 0001267813

→
Entity typeother

Related Parties

1
  • filerCIK 0001615437

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:05 PM ET
Size
5.2 KB
View on SEC.gov